Anadolu Medical Center
Anadolu Medical Center
Turchia, Istanbul
Zafer Gulbas
49 anni di esperienza • 3315+ trattamenti eseguiti
accreditamenti :
Clinica certificata da :
| Turchia | Austria | Spagna | |
| Tipizzazione HLA | da $200 | da $500 | da $200 |
Bookimed non aggiunge costi extra ai prezzi di Tipizzazione HLA. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Tipizzazione HLA al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Tipizzazione HLA e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Tipizzazione HLA.
Il professor Zafer Gülbaş — ematologo-oncologo, fondatore e direttore del Centro Trapianti di Midollo Osseo dell'Anadolu Medical Center, che è tra i più grandi in Europa.
Perché i pazienti scelgono e si fidano del Dr. Gülbaş:
Dr. Ceyhun Bozkurt is a pediatric hematologist-oncologist at Medical Park Bahcelievler Hospital. He serves as the clinical director and vice director of the stem cell transplant unit. Dr. Bozkurt focuses on childhood leukemia, bone marrow transplants, and neuroblastoma. He completed specialized observerships at Harvard University and Cincinnati Children's Hospital.
Dr. Bülent Ünal is a general surgeon and surgical oncologist. He is Head of General Surgery and Surgical Oncology at Florence Nightingale Hospital. He graduated from Çukurova University in 1996. He completed his general surgery residency at Ankara Numune Training and Research Hospital in 2001. He finished a minor specialization in surgical oncology at İnönü University in 2012.
In 2008, he was an NCI Short-Term Scientist at the University of Pittsburgh Medical Center for 10 months. He trained in sentinel node techniques and ductoscopy. In 2010, he completed transplantation and oncology training at the University of Giessen and Marburg. He has many international publications and book chapters. His co-authored series include 128 living-donor liver recipients, 26 Fournier gangrene cases, and 18 diaphragmatic injuries.
He serves on the Board of the Surgical Oncology Association. He is also a member of several Turkish and international surgical societies.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.